The market doesnt know what a good thing is anymore.
This was a good result. Revenue up 16%, Net Profit up +9%(above consensus), Paying a dividend.
Of course margins are going to be Squeezed in a high inflation environment, what do people expect.
The effects of GLP-1 on Sales are pure speculation and coming from the mouths of shorters and fear-mongers. With another quarter of revenue growth, this fact will be realised by the market and the SP will head north of $30 once again.
Time to buy some more RMD.
All IMO DYOR
Ann: ResMed Announces Results for the First Quarter of FY2024, page-24
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.60 |
Change
0.150(0.42%) |
Mkt cap ! $22.88B | |||
| Open | High | Low | Value | Volume |
| $35.30 | $35.74 | $35.25 | $86.15M | 2.422M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98 | $35.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.60 | 6713 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |